| Characteristic | Percentage of population |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Sources
Release date
September 2017
Region
Worldwide
Survey time period
2016
Supplementary notes
Clinical trial penetration is calculated by dividing the number of enrolled patients in clinical trials in 2016 by the population.
* 5EU includes the United Kingdom, Germany, France, Spain and Italy.
Citation formats









